Tradestie Institutional Equity Comparison Engine

INTG vs ICCC โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ICCC Overall Edge

ICCC Captures Institutional Edge (2โ€“1 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Immucell Corp (ICCC) driven by superior Valuation, Momentum & Technical while INTG counters with relative strength in Growth & Margin. Fundamentally, INTG trades at N/M Forward P/E with 16.1% operating margin (+13.3% YoY revenue) versus ICCC at N/M Forward P/E and 15.2% operating margin (+11.5% YoY). In options structure, INTG sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ICCC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner ICCC
INTG N/M vs ICCC N/M Fwd P/E
Growth & Margin Winner INTG
Op Margin 16.1% vs 15.2% ยท YoY +13.3% vs +11.5%
Momentum & Technical Winner ICCC
1Y +11.4% vs +88.8% ยท 52W Pos 61% vs 91%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
INTG NASDAQ
Intergroup Corporation (The)
Operators Of Apartment Buildings
$41.48
-0.65% 1D
Market Cap $89.7M
1M Return +28.1%
1Y Return +11.36%
Forward P/E N/M
Unified AI Score
32.5 / 100 SELL
Tech 15.0 Fund 33.0 Flow 50.0 Mom 30.0
ICCC NASDAQ
Immucell Corp
In Vitro & In Vivo Diagnostic Substances
$11.42
+6.23% 1D
Market Cap $97.7M
1M Return +6.23%
1Y Return +88.76%
Forward P/E N/M
Unified AI Score
43.8 / 100 HOLD
Tech 15.0 Fund 48.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: INTG +11.36% ICCC +88.76% Spread: +66.8 pp (ICCC Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period INTG Revenue ICCC Revenue INTG Op. Margin ICCC Op. Margin Margin Edge
FY2019 $70M $10M 20.3% -7.0% INTG
FY2020 $60M $20M 8.4% -9.0% INTG
FY2021 $30M $20M -17.0% 1.3% ICCC
FY2022 $50M $20M 7.8% -12.4% INTG
FY2023 $60M $20M 7.5% -32.9% INTG
FY2024 $60M $30M 2.5% -6.2% INTG
FY2025 $60M $30M 11.9% 6.0% INTG
FY2026 $70M N/A 16.0% N/A INTG

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: INTG (3) vs ICCC (5)
Institutional Metric INTG ICCC Criterion Row Winner
Market Capitalization Scale $89.7M $97.7M Larger Scale Tie
Trailing P/E Ratio Valuation 58.8x 56.6x Lower Multiple ICCC
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +13.3% +11.5% Higher Growth INTG
Operating Margin (TTM) Profitability 16.1% 15.2% Higher Margin INTG
Net Profit Margin Profitability 2.2% 2.6% Higher Margin ICCC
Return on Equity (ROE) Capital Efficiency 0.0% 2.6% Higher ROE ICCC
52-Week Range Position Momentum 61% ($25โ€“$52) 91% ($5โ€“$12) Stronger Trend ICCC
Beta / 30D Volatility Risk Regime -0.14ฮฒ ยท 42% Vol 0.24ฮฒ ยท 46% Vol Lower Realized Risk INTG
Unified Institutional Score Composite Signal 32.5 / 100 (SELL) 43.8 / 100 (HOLD) Higher Composite ICCC

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full INTG vs ICCC Buy Guide
INTG UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live INTG Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ICCC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ICCC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither INTG nor ICCC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.